James A Sloand

Summary

Affiliation: University of Rochester
Country: USA

Publications

  1. ncbi request reprint A double-blind, placebo-controlled trial of intravenous iron dextran therapy in patients with ESRD and restless legs syndrome
    James A Sloand
    Department of Medicine, Nephrology Division, University of Rochester School of Medicine, Rochester, NY, USA
    Am J Kidney Dis 43:663-70. 2004
  2. ncbi request reprint Improved control of resistant hypertension with device-mediated electrical carotid sinus baroreflex stimulation
    James A Sloand
    Division of Medicine, Department of Nephrology, University of Rochester, Rochester, NY 14620, USA
    J Clin Hypertens (Greenwich) 9:716-9. 2007
  3. ncbi request reprint Treating hyperparathyroidism with cinacalcet HCl (Sensipar)
    James A Sloand
    Nephrology Division, University of Rochester, Rochester, NY, USA
    Nephrol Nurs J 34:341-2. 2007
  4. ncbi request reprint Normalization of lithium-induced hypercalcemia and hyperparathyroidism with cinacalcet hydrochloride
    James A Sloand
    University of Rochester School of Medicine, Department of Medicine, Nephrology and Infectious Disease Division, Rochester, NY, USA
    Am J Kidney Dis 48:832-7. 2006
  5. ncbi request reprint Electrical stimulation of the carotid sinus for the treatment of resistant hypertension
    J D Filippone
    Program in Heart Failure and Transplantation, Universityof Rochester, Cardiology Division, 601 Elmwood Avenue, Box 679T, Rochester, New York 14642 8679, USA
    Curr Hypertens Rep 8:420-4. 2006
  6. pmc Increased cardiovascular risk associated with reduced kidney function
    Timothy P Ryan
    Division of Epidemiology, Department of Community and Preventive Medicine, University of Rochester School of Medicine and Dentistry, Rochester, NY 14642, USA
    Am J Nephrol 29:620-5. 2009
  7. ncbi request reprint B cell depletion as a novel treatment for systemic lupus erythematosus: a phase I/II dose-escalation trial of rituximab
    R John Looney
    University of Rochester School of Medicine and Dentistry, Rochester, New York 14642, USA
    Arthritis Rheum 50:2580-9. 2004
  8. ncbi request reprint Chronic kidney disease prevalence and rate of diagnosis
    Timothy P Ryan
    Department of Community and Preventive Medicine, Division of Epidemiology, University of Rochester School of Medicine and Dentistry, Rochester, NY 14642, USA
    Am J Med 120:981-6. 2007
  9. ncbi request reprint Wrestling with restless legs
    James A Sloand
    Sleep Med 6:295-6. 2005
  10. ncbi request reprint Vascular disease in an expanding world: seeking answers inside and outside of the box
    James A Sloand
    J Clin Hypertens (Greenwich) 9:246-8. 2007

Detail Information

Publications10

  1. ncbi request reprint A double-blind, placebo-controlled trial of intravenous iron dextran therapy in patients with ESRD and restless legs syndrome
    James A Sloand
    Department of Medicine, Nephrology Division, University of Rochester School of Medicine, Rochester, NY, USA
    Am J Kidney Dis 43:663-70. 2004
    ..Because RLS has been associated with iron deficiency, we sought to investigate the effects of intravenous (IV) iron dextran on symptoms of RLS in a double-blind placebo-controlled trial...
  2. ncbi request reprint Improved control of resistant hypertension with device-mediated electrical carotid sinus baroreflex stimulation
    James A Sloand
    Division of Medicine, Department of Nephrology, University of Rochester, Rochester, NY 14620, USA
    J Clin Hypertens (Greenwich) 9:716-9. 2007
  3. ncbi request reprint Treating hyperparathyroidism with cinacalcet HCl (Sensipar)
    James A Sloand
    Nephrology Division, University of Rochester, Rochester, NY, USA
    Nephrol Nurs J 34:341-2. 2007
  4. ncbi request reprint Normalization of lithium-induced hypercalcemia and hyperparathyroidism with cinacalcet hydrochloride
    James A Sloand
    University of Rochester School of Medicine, Department of Medicine, Nephrology and Infectious Disease Division, Rochester, NY, USA
    Am J Kidney Dis 48:832-7. 2006
    ....
  5. ncbi request reprint Electrical stimulation of the carotid sinus for the treatment of resistant hypertension
    J D Filippone
    Program in Heart Failure and Transplantation, Universityof Rochester, Cardiology Division, 601 Elmwood Avenue, Box 679T, Rochester, New York 14642 8679, USA
    Curr Hypertens Rep 8:420-4. 2006
    ..The carotid stimulator may be a safe and effective therapeutic option for patients with resistant hypertension...
  6. pmc Increased cardiovascular risk associated with reduced kidney function
    Timothy P Ryan
    Division of Epidemiology, Department of Community and Preventive Medicine, University of Rochester School of Medicine and Dentistry, Rochester, NY 14642, USA
    Am J Nephrol 29:620-5. 2009
    ..The objective of this study was to investigate the relationship between level of kidney function and the risk of cardiovascular mortality in a diverse population...
  7. ncbi request reprint B cell depletion as a novel treatment for systemic lupus erythematosus: a phase I/II dose-escalation trial of rituximab
    R John Looney
    University of Rochester School of Medicine and Dentistry, Rochester, New York 14642, USA
    Arthritis Rheum 50:2580-9. 2004
    ..B lymphocytes have been shown to play fundamental pathogenic roles in SLE, and therefore, elimination of B cells with the use of rituximab may represent a new therapy for SLE...
  8. ncbi request reprint Chronic kidney disease prevalence and rate of diagnosis
    Timothy P Ryan
    Department of Community and Preventive Medicine, Division of Epidemiology, University of Rochester School of Medicine and Dentistry, Rochester, NY 14642, USA
    Am J Med 120:981-6. 2007
    ....
  9. ncbi request reprint Wrestling with restless legs
    James A Sloand
    Sleep Med 6:295-6. 2005
  10. ncbi request reprint Vascular disease in an expanding world: seeking answers inside and outside of the box
    James A Sloand
    J Clin Hypertens (Greenwich) 9:246-8. 2007